November 16, 2015
Novartis shows its Contoura Vision
Novartis’ division and eye care specialist Alcon, is introducing its latest advancement in its WaveLightrefractive portfolio Contoura Vision.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
November 13, 2015
Roche’s site exits could affect approx 1,200 positions. Phased approach to cease production
Roche’s Media Spokesperson, Dr. Ulrike Engels-Lange, said in an email sent to Pharmaceutical Daily that the site exits are expected to affect approximately 1,200 positions.
November 13, 2015
Daraprim and Vecamyl sales brings Turing $5.6 million in 3Q 2015, New Drug applications on the way
Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, reported net revenue $5.6 million for the third quarter 2015.
November 12, 2015
Roche exits four manufacturing sites, job cuts imminent
Swiss-based Roche plans to exit four manufacturing sites globally. Workforce reduction is imminent.
November 12, 2015
Silence Therapeutics welcomes new board member
Silence Therapeutics plc, a London-headquartered drug development company, dealing with the delivery of novel RNA interference (RNAi) therapeutics for the treatment…
November 12, 2015
Study shows IONA test can predict the presence of Down’s, Edward’s, and Patau’s syndrome
Study demonstrates the IONA test can accurately predict the presence of the trisomies 21, 18, and 13. Being user-friendly, cost effective and CE-marked will overcome some of the limitations of existing commercial technologies to facilitate implementation in local laboratories.
November 11, 2015
4D pharma gets OK for clinical trial of Thetanix
4D pharma has obtained regulatory and ethical approval for a phase 1 clinical trial in respect of Thetanix.
November 11, 2015
Biofrontera’s business not affected by ongoing approval processes
Biofrontera has announced that there have been no new operational developments or matters which have arisen in relation to the ongoing approval processes or other operational aspects of the Company.
November 6, 2015
AstraZeneca buys ZS Pharma
AstraZeneca has entered into a definitive agreement to acquire Nasdaq-listed ZS Pharma, a biopharmaceutical company based in San Mateo, California.
November 6, 2015
Sanofi and Lexicon to develop sotagliflozin (for diabetics)
Sanofi and Lexicon Pharmaceuticals have entered into a collaboration and license agreement for the development and commercialization of sotagliflozin, an investigational new oral dual inhibitor of sodium-glucose cotransporters 1 and 2 (SGLT-1 and SGLT-2), which could be a potential treatment option for people with diabetes.